Dishman Specialty Chemicals

Ahmedabad, India· Est. 1983

A global CDMO providing development and manufacturing services for complex small molecule APIs, including highly potent compounds and vitamin D analogues.

imdcal.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

A global CDMO providing development and manufacturing services for complex small molecule APIs, including highly potent compounds and vitamin D analogues.

Broad PharmaceuticalHealthcarePersonal Care

Technology Platform

Integrated development and manufacturing platform for complex small molecules, with specialized expertise in Highly Potent API (HPAPI) handling, vitamin D analogue synthesis, and quaternary ammonium chemistry.

Opportunities

Growth in outsourcing of complex and highly potent API manufacturing, expansion of its niche product portfolio (e.g., vitamin D analogues), and leveraging its global regulatory approvals to capture market share in regulated markets.

Risk Factors

Intense competition in the CDMO space, operational and compliance risks across multiple international facilities, client concentration risk, and vulnerability to fluctuations in pharmaceutical R&D investment.

Competitive Landscape

Competes with global CDMOs like Lonza, Cambrex, and Piramal Pharma Solutions, as well as Indian peers like Divi's Laboratories and Laurus Labs. Differentiation is based on specific expertise in HPAPIs and vitamin D chemistry, integrated service offerings, and a cost-competitive global footprint.

More companies in India →